GreenLight Biosciences Holdings
NASDAQ: GRNA0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Global Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Andrey Juan Zarur
- Employees
- 280
- Headquarters
- Medford, United States
- IPO year
- 2022
- Market cap
- $45.4M
- Website
- https://greenlightbiosciences.com
Loading GRNA…
Loading profile data…Frequently asked questions about GRNA
What does GreenLight Biosciences Holdings (GRNA) do?
GreenLight Biosciences Holdings is a biotechnology firm focused on developing and commercializing ribonucleic acid (RNA) solutions. Its innovative products serve both the human health and agricultural industries. The company's human health portfolio includes mRNA vaccines and various therapeutic treatments, while its agricultural offerings featu...
Where does GRNA trade?
GreenLight Biosciences Holdings (GRNA) trades on the NASDAQ Global Market.
What sector is GRNA in?
GreenLight Biosciences Holdings (GRNA) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of GreenLight Biosciences Holdings?
Andrey Juan Zarur is the chief executive officer of GreenLight Biosciences Holdings (GRNA).
Where is GreenLight Biosciences Holdings headquartered?
GreenLight Biosciences Holdings is headquartered in United States.
Does GRNA pay a dividend?
GreenLight Biosciences Holdings (GRNA) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did GRNA go public?
GreenLight Biosciences Holdings (GRNA) completed its initial public offering in 2022.